欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/6882/003
药品名称Rivastigmin-ratiopharm 13,3 mg/24 Stunden transdermales Pflaster
活性成分
    • rivastigmine 13.3 mg/24h
剂型Transdermal patch
上市许可持有人ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称Germany (DE)
Rivastigmin-ratiopharm 13,3 mg/24 Stunden transdermales Pflaster
互认成员国 - 产品名称
    • Belgium (BE)
      Rivastigmine Teva 13,3 mg/24 u pleister voor transdermaal gebruik
    • Netherlands (NL)
      Rivastigmine Teva 13,3 mg/24 u
    • Austria (AT)
    • Iceland (IS)
    • Spain (ES)
    • Sweden (SE)
    • Portugal (PT)
    • Slovenia (SI)
许可日期2021/11/18
最近更新日期2024/08/26
药物ATC编码
    • N06DA03 rivastigmine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase